Lichen sclerosus et atrophicus and morphea occurring over different sites in a young male: an interesting association
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20251052Keywords:
Lichen sclerosis et atrophicus, MorphoeaAbstract
Lichen sclerosus et atrophicus (LSA) is a chronic inflammatory disorder primarily affecting the female genitalia, presenting as white, atrophic skin plaques; extra-genital LSA is less common, occurring in about 15% of cases. Morphea, or localized scleroderma, is a rare connective tissue disease that typically presents with sclerotic skin plaques. We report a 15-year male patient with dark coloured itchy lesions over lower back since childhood and left knee since 6 months. Various investigations, including hemogram, serum biochemistry, thyroid profile, lipid profile, viral markers, and histopathological examination, were conducted. Patient was treated with potent topical corticosteroid, antihistamines and methotrexate 10 mg weekly once for 6 weeks with moderate improvement. Common immune-pathogenic mechanisms and trigger factors such as genetic predisposition and trauma may be responsible for development of 2 different immune mediated dermatoses in the same patient.
Metrics
References
Virdi SK, Kanwar AJ. Generalized morphea, lichen sclerosis et atrophicus associated with oral submucosal fibrosis in an adult male. Indian J Dermatol Venereol Leprol. 2009;75:56-9. DOI: https://doi.org/10.4103/0378-6323.45222
Gordon ER, Adeuyan O, Fahmy LM, Schreidah CM, Trager MH, Lapolla BA, et al. Extragenital lichen sclerosus et atrophicus-morphea overlap as an initial presentation of genital lichen sclerosus. Dermatol Online J. 2024;15:30. DOI: https://doi.org/10.5070/D330263585
Siskou S, Drongoula O, Grammatikopoulou J, Nivatsi P, Noukari D, Kokarida A, et al. Coexistence of Lichen Sclerosus Et Atrophicus and Morphea in the Same Lesion: A Case Report. Cureus. 2023;15(8):e43062. DOI: https://doi.org/10.7759/cureus.43062
Arif T, Fatima R, Sami M. Extragenital lichen sclerosus: A comprehensive review. Australas J Dermatol. 2022;63(4):452-62. DOI: https://doi.org/10.1111/ajd.13890
Paulis G, Berardesca E. Lichen sclerosus: the role of oxidative stress in the pathogenesis of the disease and its possible transformation into carcinoma. Res Rep Urol. 2019;11:223-32. DOI: https://doi.org/10.2147/RRU.S205184
Khan Mohammad Beigi P. The Immunogenetics of Morphea and Lichen Sclerosus. Adv Exp Med Biol. 2022;1367:155-72. DOI: https://doi.org/10.1007/978-3-030-92616-8_7
Fistarol SK, Itin PH. Diagnosis and treatment of lichen sclerosus: an update. Am J Clin Dermatol. 2013;14(1):27-47. DOI: https://doi.org/10.1007/s40257-012-0006-4
Nishioka S. Histological comparison of morphea and lichen sclerosus et atrophicus. Kurume Med J. 1997;44(2):83-90. DOI: https://doi.org/10.2739/kurumemedj.44.83
Narbutt J, Hołdrowicz A, Lesiak A. Morphea - selected local treatment methods and their effectiveness. Reumatologia. 2017;55(6):305-13. DOI: https://doi.org/10.5114/reum.2017.72628
George R, George A, Kumar TS. Update on Management of Morphea (Localized Scleroderma) in Children. Indian Dermatol Online J. 2020;11(2):135-45. DOI: https://doi.org/10.4103/idoj.IDOJ_284_19
Das A, Gupta S, Singh S, Pant L. Coexisting morphea with lichen sclerosus et atrophicus in a single lesion - a rare case report. Bangl J Med Sci Dhaka. 2016;15(1):145-7. DOI: https://doi.org/10.3329/bjms.v15i1.20483